Dana-Farber Cancer Institute; Harvard Medical School
Dr. Bradley A. McGregor is currently a Medical Oncologist specializing in genitourinary malignancies at the Dana-Farber Cancer Institute. Completing is undergraduate and medical school education at Tufts University; he then joined the United States Air Force at the San Antonio Uniformed Services Health Education Consortium. While in the military, he completed his post-graduate training in internal medicine, medical oncology and hematology. While in the uniformed services, he provided oncologic care to active-duty members, their family members and retirees across the spectrum of benign hematology and medical oncology in San Antonio, TX and northern California at Travis Air Force Base. He served in Afghanistan as the Deputy Commander for the NATO led Medical Training Advisory Group where he mentored the Afghan physicians. Reaching the rank of Lieutenant Colonel and receiving the Meritorious Service medal, Dr McGregor left the Air Force in July of 2016 and came to Dana Farber where he is a senipor Physician in the Lank Center for for Genitourinary Oncology at DFCI. Sevrign as clinical directgor since 2016., he has recently been appointed dirctor of clinical research operations. He has served as principal investigator for several trials while leading IITs in treatment of rare genitourinary malignancies, non-clear cell renal cell carcinoma.
Astellas (Individual(s) Involved: Self): Consultant; Bristol Myer Squibb (Individual(s) Involved: Self; Clinical Condition: Renal Cell, Bladder): Advisory Board, Consultant, Grant/Research Support; Calithera (Individual(s) Involved: Self; Clinical Condition: Renal Cell): Consultant, Grant/Research Support; Dendreon (Individual(s) Involved: Self; Clinical Condition: Prostate): Consultant; Eisai (Individual(s) Involved: Self; Clinical Condition: Renal Cell): Consultant; EMD Serono (Individual(s) Involved: Self; Clinical Condition: Renal Cell, Bladder): Consultant; Exelixis (Individual(s) Involved: Self; Clinical Condition: Renal Cell): Advisory Board, Consultant, Grant/Research Support; Pfizer, Inc. (Individual(s) Involved: Self; Clinical Condition: Renal Cell, Bladder): Advisory Board, Consultant, Grant/Research Support; SeaGen (Individual(s) Involved: Self; Clinical Condition: Bladder): Consultant, Grant/Research Support
Wednesday, March 9, 2022
9:00 AM – 11:15 AM
Wednesday, March 9, 2022
9:05 AM – 9:25 AM
Wednesday, March 9, 2022
10:25 AM – 11:15 AM
Thursday, March 10, 2022
2:45 PM – 3:35 PM
Thursday, March 10, 2022
2:50 PM – 3:35 PM